CSPC Pharma HKG:1093 – Hong Kong Blue Chip stock

CSPC Pharma HKG:1093 – Hong Kong Blue Chip stock

CSPC Pharma (HKG:1093)

Hong Kong Blue Chip Stock • Sector: Medicine

Last updated: 25-Mar
Next ex-dividend date: N/A


August 2020 the first Interim Dividend was announced. For CSPC Pharma Dividend Growth and Safety look promising, but is this a dividend stock that will keep growing? It did for the last 5 years. Well with a P/E and Price-to-book ratios like this, the price seems higher than the value of this stock.

Stock Value Score

This score indicates whether the stock currently appears undervalued, fairly priced, or expensive,
based on key valuation metrics such as earnings, book value, and cash flow.

P/E ratio 21.03
P/B ratio 2.66
EPS 0.4
Beta 0.69

Beta above 1 suggests higher volatility. Below 1 suggests more stability relative to the market.

So what’s the takeaway?
Based on current valuation metrics, the stock appears .
Future changes in earnings, cash flow, or price could materially shift this assessment.

Champion Members see the full 3-Pillar scorecard:
Dividend Growth,
Dividend Safety,
Stock Value.


Learn more about Champion Membership

You need to be logged in to view the rest of the content. Please .